Klivira
Request demo

Streamlining Sevocity Humira Prior Authorization Workflows

Specialty ambulatory practices leveraging Sevocity for patient care require efficient processes for high-cost biologics. Klivira directly integrates to automate and accelerate Sevocity Humira prior authorization, addressing the complexities of adalimumab approvals.

Managing prior authorizations for specialty medications like Humira (adalimumab) within a cloud-based EMR like Sevocity presents specific operational challenges. The need to navigate biosimilar step therapy, specialty pharmacy routing, and payer-specific clinical criteria can strain revenue cycle operations and delay patient access. Klivira provides a targeted solution to automate these intricate workflows, directly integrating with Sevocity to optimize the PA process for TNF-alpha inhibitors.

Sevocity's Role in Humira (Adalimumab) Prior Authorization Workflows

Sevocity's customizable cloud EHR, with its robust specialty templates, is instrumental in documenting the clinical rationale for Humira prescriptions. While Sevocity facilitates comprehensive patient charting and order entry, the prior authorization submission and tracking process often extends beyond the EMR's native capabilities. Klivira bridges this gap, connecting Sevocity's rich clinical data to payer requirements for adalimumab authorizations.

Key Prior Authorization Considerations for Humira in Sevocity

  • **Biosimilar Step Therapy:** Payer mandates often require trial and failure of adalimumab biosimilars before original Humira approval.
  • **Specialty Pharmacy Routing:** Ensuring prescriptions are routed to the correct in-network specialty pharmacy, which often has its own PA requirements.
  • **Indication-Specific Criteria:** Humira is approved for multiple conditions (e.g., rheumatoid arthritis, Crohn's disease, psoriasis); documentation must align with the specific diagnosis.
  • **Medical vs. Pharmacy Benefit:** Determining whether Humira falls under the patient's medical or pharmacy benefit is critical for correct submission type (X12 278 vs. NCPDP SCRIPT).
  • **Documentation of Prior Therapies:** Payers typically require evidence of failed conventional or other biologic therapies.

Klivira's Intelligent Integration with Sevocity for Humira PAs

Klivira leverages Sevocity APIs to extract the necessary clinical data points to construct a complete and accurate prior authorization request for Humira. Our platform automatically pulls relevant information such as diagnosis codes, problem list entries, medication history, lab results (e.g., CRP, ESR), and documented treatment plans from Sevocity. This direct integration minimizes manual data entry, reduces human error, and ensures the PA submission is clinically robust.

Navigating Pharmacy and Medical Benefits for Adalimumab within Sevocity

Humira, like many specialty biologics, can be covered under a patient's medical benefit (e.g., administered in-office) or pharmacy benefit (e.g., self-administered at home). Klivira's platform is designed to identify the appropriate benefit pathway based on the prescription details and payer rules, then generate and submit the correct ePA transaction—whether it's an X12 278 for medical benefit or an NCPDP SCRIPT for pharmacy benefit—directly from the data housed in Sevocity.

Optimizing Sevocity Documentation for Humira Prior Authorization Success

To maximize prior authorization approval rates for Humira, specialty practices should ensure comprehensive documentation within Sevocity. Key data points include detailed progress notes outlining disease activity, specific diagnostic imaging reports, relevant lab values, and clear records of previous treatment failures. Klivira's integration helps identify and surface these critical elements from Sevocity's structured and unstructured data, ensuring all payer requirements are met.

Frequently asked questions

How does Klivira access Sevocity data for Humira prior authorizations?

Klivira integrates with Sevocity via its established APIs, allowing for secure and compliant extraction of relevant patient demographic, clinical, and prescription data. This connection ensures that all necessary information for a Humira PA—from diagnosis codes to lab results—is accurately and efficiently transferred for submission.

Does Klivira handle biosimilar step therapy requirements for Humira within Sevocity's workflow?

Yes, Klivira is specifically designed to manage complex payer rules, including biosimilar step therapy for adalimumab. Our platform analyzes payer criteria and leverages clinical data from Sevocity to guide the PA process, ensuring that all step therapy requirements are addressed in the submission.

Can Klivira manage both medical and pharmacy benefit prior authorizations for Humira prescribed in Sevocity?

Absolutely. Klivira's platform is equipped to handle both medical benefit (X12 278) and pharmacy benefit (NCPDP SCRIPT) ePA submissions for Humira. We intelligently determine the correct pathway based on the prescription and payer, streamlining the process regardless of how the drug is covered.

How does Sevocity's specialty pharmacy routing interact with Klivira for Humira PAs?

While Sevocity facilitates the initial prescription and routing, Klivira manages the prior authorization specific to that specialty pharmacy and payer. Our system works in conjunction with the pharmacy's requirements, ensuring that the PA is approved and the prescription can proceed through the designated specialty pharmacy network.

What specific Sevocity documentation is most critical for Humira prior authorization?

For Humira PAs, critical Sevocity documentation includes the patient's problem list, detailed diagnosis codes, comprehensive progress notes describing disease activity and severity, relevant lab results (e.g., CRP, ESR), and a clear history of failed prior therapies. Klivira optimizes the extraction and presentation of these data points for payers.

Related coverage

Other sevocity prior auth coverage

Ready to automate prior auth for this integration?

See how Klivira automates prior authorizations for your team.

Request a demo